385P Efficacy and safety of pyrotinib in untreated, advanced non-small cell lung cancer with HER2 mutations: A parallel, multi-center, multi-cohort patient-centric study (CTONG1702 and 1705).

Authors :: Liu, S-Y.M.
Tu, H-Y.
Wei, X-W.
Yan, H-H.
Dong, X.
Cui, J.
Zhou, Z.
Xu, C.
Zheng, M.
Li, Y.
Wang, Z.
Du, Y.
Chen, Y.
Ma, R.
Wang, B.
Cang, S.
Yang, J-J.
Chen, H.
Zhou, Q.
Wu, Y-L.
Source :: Annals of Oncology. Nov2022 Suppl 9, Vol. 33, pS1591-S1591. 1p.
Publication Year :: 2022

Subjects :: *NON-small-cell lung carcinoma
*EPIDERMAL growth factor receptors

Full Text Access

Tools